84 results
424B5
DTIL
Precision Biosciences Inc
1 Mar 24
Prospectus supplement for primary offering
6:32pm
causes inflammation and damage to the liver, leading to chronic infection and increased risk of death from liver cancer or cirrhosis. There is no cure
424B5
DTIL
Precision Biosciences Inc
29 Feb 24
Prospectus supplement for primary offering
5:19pm
and increased risk of death from liver cancer or cirrhosis. There is no cure for chronic HBV and current treatments rarely result in functional cure, primarily
8-K
EX-10.4
d4p33kurvuq wmep3
23 Jan 24
Departure of Directors or Certain Officers
5:29pm
8-K
EX-10.1
xt0jb
23 Jan 24
Departure of Directors or Certain Officers
5:29pm
8-K
EX-10.3
xq55v
23 Jan 24
Departure of Directors or Certain Officers
5:29pm
8-K
EX-10.2
am66f1pttzl6hae74255
23 Jan 24
Departure of Directors or Certain Officers
5:29pm
8-K
EX-3.1
kdtrcmpb
22 Dec 23
Amendments to Articles of Incorporation or Bylaws
8:12am
8-K
EX-99.1
zdri7t 16
4 Aug 23
Precision BioSciences Reports Second Quarter 2023 Financial Results and Provides Business Update
7:42am
8-K
yzdokbba
8 Jun 22
PBCAR0191 Achieved Peak CAR T Cell Expansion Matching Data from Autologous CAR T Peak Expansion in Long Term Durable Responders
7:30am
8-K
EX-99.1
12vzbtyb
8 Jun 22
PBCAR0191 Achieved Peak CAR T Cell Expansion Matching Data from Autologous CAR T Peak Expansion in Long Term Durable Responders
7:30am
8-K
4nbkqjv433ww107eqw
31 May 22
Precision BioSciences Appoints Melinda Brown to Board of Directors
8:05am